Previous Close | 256.00 |
Open | 256.00 |
Bid | 250.00 x N/A |
Ask | 260.00 x N/A |
Day's Range | 256.00 - 256.00 |
52 Week Range | 256.00 - 390.00 |
Volume | |
Avg. Volume | 0 |
Market Cap | 7.373B |
Beta (5Y Monthly) | 0.94 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -9.96 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The first-quarter results for Bio-Rad Laboratories, Inc. ( NYSE:BIO ) were released last week, making it a good time to...
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]